Biostar Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Biostar Pharmaceuticals prevailing Real Value cannot be determined due to lack of data. The current price of Biostar Pharmaceuticals is $0.0. Our model approximates the value of Biostar Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of 0.0266, profit margin of 2.94 %, and Current Valuation of 316.46 K as well as examining its technical indicators and probability of bankruptcy.
Biostar Pharmaceuticals Total Value Analysis
Biostar Pharmaceuticals is currently projected to have valuation of 316.46 K with market capitalization of 94, debt of 0, and cash on hands of 364.97 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Biostar Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
316.46 K | 94 | 0 | 364.97 K |
Biostar Pharmaceuticals Investor Information
The company has price-to-book (P/B) ratio of 0.01. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biostar Pharmaceuticals had not issued any dividends in recent years. The entity had 1:7 split on the 5th of February 2016. Based on the key indicators related to Biostar Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Biostar Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Biostar Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biostar Pharmaceuticals has an asset utilization ratio of 0.75 percent. This suggests that the Company is making $0.007477 for each dollar of assets. An increasing asset utilization means that Biostar Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Biostar Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 317.79 K. Net Loss for the year was (5.7 M) with profit before overhead, payroll, taxes, and interest of 915.17 K.Biostar Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Biostar Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.3 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |